- Home
- VATE vs ATRA Comparison
VATE vs ATRA Comparison
Compare VATE & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VATE | ATRA |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.4M | 94.2M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VATE | ATRA |
|---|---|---|
| Price | $6.54 | $8.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | ★ 73.7K | 36.6K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,246,000,000.00 | $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,334.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $3.75 | $3.92 |
| 52 Week High | $21.30 | $19.15 |
Technical Indicators
Market Signals| Indicator | VATE | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | 49.17 |
| Support Level | $6.48 | $8.96 |
| Resistance Level | $8.23 | $9.64 |
| Average True Range (ATR) | 0.40 | 0.67 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 8.70 | 65.31 |
Price Performance
Historical ComparisonAbout VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.